US012 is a clinical research site located in Meridian, Idaho, United States 83642.
Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.
US012 has participated in 1 clinical trials.
Therapeutic areas: Influenza, Human.
Sponsors: Novavax.
Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
US012 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
US012 has 1 clinical trials on record. Their work covers Influenza, Human.
US012 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.